Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies

BACKGROUND: Studies have shown increased gastric cancer risk in users of proton pump inhibitors (PPI) and histamine-2 receptor antagonists, questioning the safety of gastric acid suppression. Therefore, we conducted a case–control study within the Scottish Primary Care Clinical Informatics Unit (PCC...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Liu, Peipei, McMenamin, Úna C., Johnston, Brian T., Murchie, Peter, Iversen, Lisa, Lee, Amanda J., Vissers, Pauline A. J., Cardwell, Chris R.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7374738/
https://ncbi.nlm.nih.gov/pubmed/32367073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0860-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki